Unknown

Dataset Information

0

Comparison crystal structure conformations of two structurally related biphenyl analogues: 4,4'-bis-[3-(pyrrolidin-1-yl)prop-1-yn-1-yl]-1,1'-biphenyl and 4,4'-bis-{3-[(S)-2-methyl-pyrrolidin-1-yl]prop-1-yn-1-yl}-1,1'-biphen-yl.


ABSTRACT: The title compounds, C26H28N2, (I), and C28H32N2, (II), were designed based on the structure of the potent ?9?10 nicotinic acetyl-choline receptor antagonist ZZ161C {1,1'-[[1,1'-biphen-yl]-4,4'-diylbis(prop-2-yne-3,1-di-yl)]bis-(3,4-di-methyl-pyridin-1-ium) bromide}. In order to improve the druglikeness properties of ZZ161C for potential oral administration, the title compounds (I) and (II) were prepared by coupling 4,4'-bis-(3-bromo-prop-1-yn-1-yl)-1,1'-biphenyl with pyrrol-idine, (I), and (S)-2-methyl-pyrrolidine, (II), respectively, in aceto-nitrile at room temperature. The asymmetric unit of (I) contains two half mol-ecules that each sit on sites of crystallographic inversion. As a result, the biphenyl ring systems in compound (I) are coplanar. The biphenyl ring system in compound (II), however, has a dihedral angle of 28.76?(11)°. In (I), the two independent mol-ecules differ in the orientation of the pyrrolidine ring (the nitro-gen lone pair points towards the biphenyl rings in one mol-ecule, but away from the rings in the other). The torsion angles about the ethynyl groups between the planes of the phenyl rings and the pyrrolidine ring N atoms are 84.15?(10) and -152.89?(10)°. In compound (II), the corresponding torsion angles are 122.0?(3) and 167.0?(3)°, with the nitro-gen lone pairs at both ends of the mol-ecule directed away from the central biphenyl rings.

SUBMITTER: Wan A 

PROVIDER: S-EPMC4647364 | biostudies-literature | 2015 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Comparison crystal structure conformations of two structurally related biphenyl analogues: 4,4'-bis-[3-(pyrrolidin-1-yl)prop-1-yn-1-yl]-1,1'-biphenyl and 4,4'-bis-{3-[(S)-2-methyl-pyrrolidin-1-yl]prop-1-yn-1-yl}-1,1'-biphen-yl.

Wan Anqi A   Penthala Narsimha Reddy NR   Fifer E Kim EK   Parkin Sean S   Crooks Peter A PA  

Acta crystallographica. Section E, Crystallographic communications 20150912 Pt 10


The title compounds, C26H28N2, (I), and C28H32N2, (II), were designed based on the structure of the potent α9α10 nicotinic acetyl-choline receptor antagonist ZZ161C {1,1'-[[1,1'-biphen-yl]-4,4'-diylbis(prop-2-yne-3,1-di-yl)]bis-(3,4-di-methyl-pyridin-1-ium) bromide}. In order to improve the druglikeness properties of ZZ161C for potential oral administration, the title compounds (I) and (II) were prepared by coupling 4,4'-bis-(3-bromo-prop-1-yn-1-yl)-1,1'-biphenyl with pyrrol-idine, (I), and (S)-  ...[more]

Similar Datasets

| S-EPMC2915354 | biostudies-literature
| S-EPMC4647388 | biostudies-literature
| S-EPMC5458311 | biostudies-literature
| S-EPMC3050360 | biostudies-literature
| S-EPMC3998594 | biostudies-literature
| S-EPMC2915361 | biostudies-literature
| S-EPMC3052146 | biostudies-literature
| S-EPMC3569757 | biostudies-literature
| S-EPMC2915210 | biostudies-literature
| S-EPMC2977130 | biostudies-literature